Publications & Works

Publication Network
Articles 39
All (39)
SCI-E, SSCI, AHCI (20)
SCI-E, SSCI, AHCI, ESCI (26)
ESCI (6)
Scopus (23)
TRDizin (11)
Other Publications (6)

1. Comparison of in vitro lipolysis, sequential lipolysis – ex vivo permeability, and simultaneous lipolysis - in situ perfusion for exemestane-loaded lipid-based formulations

Timur B., Olğaç S., Yılmaz Usta D., Demirel M. A., Teksin Z. Ş.
European Journal of Pharmaceutical Sciences , vol.216, pp.1-19, 2026 (SCI-Expanded) Sustainable Development

2. Performance of oral Bosentan-loaded SNEDDS and S-SNEDDS tablets: Biodistribution in mice, echocardiography and histology studies in pulmonary arterial hypertension rat model

YILMAZ USTA D., OLĞAÇ S., DEMİREL M. A., KULA S., ELMAS Ç., Sezginer P., et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.212, 2025 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

3. Lipit Temelli Taşıyıcı Sistemler-II: Katı Kendiliğinden Emülsifiye İlaç Taşıyıcı Sistem Formülasyonlarına Bakış: Geleneksel Derleme

Yılmaz Usta D., Teksin Z. Ş.
Literatür Eczacılık Bilimleri Dergisi , vol.14, no.1, pp.17-25, 2025 (TRDizin) Sustainable Development

4. Pre-formulation Studies of Lipid-based Formulation Approach for A Poorly Water-soluble BCS Class II Model Drug: Bosentan

Yılmaz Usta D., Teksin Z. Ş.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.22, no.2, pp.140-153, 2025 (ESCI, Scopus, TRDizin) Sustainable Development

5. Preliminary Study on the Development of Orodispersible Film Containing Desloratadine

Çakmakyapan Ö., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.
Turkish Journal of Pharmaceutical Sciences , vol.22, no.1, pp.55-63, 2025 (ESCI, Scopus, TRDizin) identifier identifier identifier identifier

6. Optimization and validation of HPLC methods for in vitro and ex vivo analyses of bosentan monohydrate in FDA-recommended and biorelevant media

Yılmaz Usta D., Olğaç S., Teksin Z. Ş.
Istanbul Journal of Pharmacy , vol.54, no.3, pp.466-475, 2024 (ESCI, TRDizin) Sustainable Development

7. Lipid Based Delivery Systems-I: Overview of Self-Emulsifying Drug Delivery System Formulations: Traditional Review

Yılmaz Usta D., Teksin Z. Ş.
Literatür Eczacılık Bilimleri Dergisi , vol.13, no.3, pp.165-176, 2024 (TRDizin) Sustainable Development

8. Evaluation of Emulgel and Nanostructured Lipid Carrier-Based Gel Formulations for Transdermal Administration of Ibuprofen: Characterization, Mechanical Properties, and Ex-Vivo Skin Permeation

YILMAZ USTA D., TEKSİN Z. Ş., TUĞCU DEMİRÖZ F. N.
AAPS PHARMSCITECH , vol.25, no.5, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

9. Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex-vivo imaging

Yılmaz Usta D., Olgac S., Tımur B., Teksin Z. Ş.
International Journal of Pharmaceutics , vol.643, 2023 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

10. Evaluation of The Effects of Carob (Ceratonia siliqua L.) Fruits on the Puberty of Rats

Kılınç Uğurlu A., Bideci A., Anadol E., Süntar İ., Take Kaplanoğlu G., Gülbahar Ö., et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY , vol.15, no.2, pp.145-153, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier identifier identifier

11. QbD Application for a Fixed-Dose Combination with Biowaiver Potential: Evaluations of In Vitro and In Vivo Applications

Sarisaltik-Yasin D., Uslu A., UYAR E., ERDİNÇ M., TEKSİN Z. Ş.
JOURNAL OF PHARMACEUTICAL INNOVATION , vol.18, no.1, pp.164-181, 2023 (SCI-Expanded, Scopus) identifier identifier

12. Investigation of the effect of colloidal structures formed during lipolysis of lipid-based formulation on exemestane permeability using the in vitro lipolysis-permeation model

Timur B., Yılmaz Usta D., Teksin Z. S.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.77, 2022 (SCI-Expanded, Scopus) identifier identifier

13. Evaluation of The Effects of Carob (Ceratonia Siliqua L.) Fruits on the Puberty of Rats

Ugurlu A., Bideci A., Anadol E., Süntar İ., Take Kaplanoğlu G., Gülbahar Ö., et al.
HORMONE RESEARCH IN PAEDIATRICS , no.SUPPL 2, pp.541-542, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier

14. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment

Usta D., Timur B., TEKSİN Z. Ş.
European Journal of Pharmaceutical Sciences , vol.174, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

15. Bitkisel İlaçların Farmakokinetik-Biyoyararlanım Değerlendirmeleri ve Ruhsat Aşamaları: Geleneksel Derleme

TİMUR B., TEKSİN Z. Ş.
Literatür Eczacılık Bilimleri Dergisi , vol.11, no.1, pp.61-76, 2022 (TRDizin) identifier

16. Development and validation of an HPLC method using an experimental design for analysis of amlodipine besylate and enalapril maleate in a fixed dose combination

Sarısaltık Yaşın D., Arslantürk Bingül A., Karaküçük A. E., Teksin Z. Ş.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.18, no.3, pp.306-318, 2021 (ESCI, Scopus, TRDizin) identifier identifier identifier identifier

17. Role of Surfactants on Dissolution Behavior of Tamoxifen

İNCEÇAYIR T., Olgac S., Usta D. Y., TEKSİN Z. Ş.
DISSOLUTION TECHNOLOGIES , vol.28, no.2, 2021 (SCI-Expanded, Scopus) identifier identifier

18. Improved oral bioavailability of anticancer drug tamoxifen through complexation with water soluble cyclodextrins: in vitro and in vivo evaluation

Erdogar N., NEMUTLU E., Iskit A. B., Kara S. C., TEKSİN Z. Ş., BİLENSOY E.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , vol.96, pp.81-91, 2020 (SCI-Expanded, Scopus) identifier identifier

19. Biopharmaceutics, Pharmacokinetics and Patent Evaluations of Drugs Used in the Treatment of COVID-19: Current Status in the Development of Generic Drugs in Turkey

YILMAZ USTA D., TEKSİN Z. Ş.
GAZI MEDICAL JOURNAL , vol.31, pp.498-509, 2020 (ESCI, Scopus) Sustainable Development identifier identifier

20. Evaluation of improved oral bioavailability of ritonavir nanosuspension

Karakucuk A., TEKSİN Z. Ş., EROĞLU H., Celebi N.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.131, pp.153-158, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

21. Evaluation of biorelevant media to investigate the dissolution properties on flurbiprofen and to assess cytotoxicity effects on Caco-2 cell line

Yasin D. S., Yilmaz S., TEKSİN Z. Ş.
ISTANBUL JOURNAL OF PHARMACY , vol.48, no.3, pp.82-88, 2018 (ESCI, TRDizin) Creative Commons License identifier

22. Açlık ve Tokluk Durumlarını Taklit Eden Biyouyumlu Çözünme Ortamlarının Değerlendirilmesi

SARISALTIK YAŞIN D., TEKSİN Z. Ş.
FABAD J.Pharm.Sci , vol.48, no.3, pp.217-232, 2018 (Peer-Reviewed Journal) Sustainable Development

23. Evaluation of in vitro Dissolution Characteristics of Flurbiprofen, a BCS Class IIa Drug

YILMAZ USTA D., demirtaş ö., ökçelik c., uslu a., TEKSİN Z. Ş.
FABAD J. Pharm. Sci , vol.43, no.2, pp.27-34, 2018 (Peer-Reviewed Journal)

24. Biopharmaceutics Classification System: Evaluation on International Guidelines and Countries

SARISALTIK YAŞIN D., TEKSİN Z. Ş.
Journal of Literature Pharmacy Sciences , vol.7, no.2, pp.160-174, 2018 (TRDizin)

25. İn Vitro Çözünme Hızı Çalışmalarında Yeni Yaklaşımlar

YILMAZ USTA D., TEKSİN Z. Ş.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , vol.40, no.1, pp.33-40, 2017 (Scopus)

26. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach

Karakucuk A., Celebi N., Teksin Z. Ş.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.95, pp.111-121, 2016 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

27. BIOWAIVER APPROACH FOR BCS: DISCUSSION OF BIOWAVER MONOGRAPHS FOR IMMEDIATE-RELEASE SOLID ORAL DOSAGE FORMS

TEKSİN Z. Ş.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.50, 2013 (SCI-Expanded) identifier

28. IMPLEMENTATION OF BCS BASED BIOWAIVER IN TURKEY

TORT S., Koksal H. T., TEKSİN Z. Ş.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.50, 2013 (SCI-Expanded) identifier

29. Biyoeşdeğerlik Çalışmalarından Vazgeçilmesinde Biyofarmasötik İlaç Sınıflandırma Sistemlerinin Değerlendirilmesi Biyofarmasötik Sınıflandırma Sistemi BCS ve Biyofarmasötik İlaç Dağılım Sınıflandırma Sistemi BDDCS

SARISALTIK YAŞIN D., TEKSİN Z. Ş.
Türkiye Klinikleri Eczacılık Bilimleri Dergisi, , vol.1, no.1, pp.16-30, 2011 (Peer-Reviewed Journal)

30. Comparison of Drug Permeabilities and BCS Classification: Three Lipid-Component PAMPA System Method versus Caco-2 Monolayers

Teksin Z. Ş., Seo P. R., Polli J. E.
AAPS JOURNAL , vol.12, no.2, pp.238-241, 2010 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

31. Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen

Teksin Z. Ş., Lee I. J., Nemieboka N. N., Othman A. A., Upreti V. V., Hassan H. E., et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.72, no.2, pp.471-477, 2009 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

32. Bioavailability of Pentoxifylline Chitosan Oral Matrix Tablet in Healthy Subjects

AĞABEYOĞLU T. İ., YAMAC K., TEKSİN Z. Ş.
J. Bioequivalence & Bioavailability , vol.1, no.4, pp.115-120, 2009 (Peer-Reviewed Journal)

33. Bioavailability File: Levofloxacin

SARISALTIK YAŞIN D., TEKSİN Z. Ş.
FABAD J.Pharm.Sci , vol.32, no.4, pp.197-208, 2007 (Scopus)

34. Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system

Teksin Z. Ş., Hom K., Balakrishnan A., Polli J. E.
JOURNAL OF CONTROLLED RELEASE , vol.116, no.1, pp.50-57, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

35. Lipid composition effect on permeability across PAMPA

Seo P. R., Teksin Z. Ş., Kao J. P. Y., Polli J. E.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.29, pp.259-268, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

36. Solubility of Resin Based Restorative Materials in Different pH Values

KARACAER Ö., YAMAN S., TEKSİN Z. Ş.
J.Gazi Univ.Fac.Dent. , vol.19, no.1, pp.1-4, 2002 (TRDizin)

37. Kronofarmakokinetiğin önemi ve kronofarmasötik ilaç şekli tasarımı

TEKSİN Z. Ş., ABACIOĞLU N.
TÜFTAD , vol.9, no.3, pp.3-4, 2002 (Non Peer-Reviewed Journal)

38. Biyoeşdeğerlik çalışmalarından vazgeçme kriterlerinde yeni yaklaşımlar

TEKSİN Z. Ş.
TÜFTAD , vol.9, no.4, pp.9-11, 2002 (Non Peer-Reviewed Journal)

39. Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation

Yamac K., Kaptan K., Beyan C., Teksin Z. Ş., Agabeyoglu I., Gokgoz L.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH , vol.50, no.9, pp.827-831, 2000 (SCI-Expanded, Scopus) identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 95

1. Formulation and Physicochemical Characterization of Interleukin-2 from Various Production Sources

OLĞAÇ S., DEMİRCİ H., DİNLER DOĞANAY G., KULAKMAN C., AKBAŞ Y., OLĞAÇ A., et al.
5th Conference on Innovation in Drug Delivery, Torino, Italy, 1 - 03 October 2025, (Summary Text)

2. From In Silico to Cell Culture: Formulation Assessment of Human Interleukin-2

OLĞAÇ S., VARAN G., OLĞAÇ A., TEKSİN Z. Ş.
5th Conference on Innovation in Drug Delivery, Torino, Italy, 1 - 03 October 2025, (Summary Text)

3. Assessment of in vitro release and in vitro lipolysis for interleukin-2-loaded double self-nanoemulsifying drug delivery system

OLĞAÇ S., TİMUR B., TEKSİN Z. Ş.
JOINT EUFEPS - ÖPhG Meeting 2025, Viyana, Austria, 19 - 21 February 2025, (Summary Text)

4. In vitro performance of Exemestan-loaded SNEDDS formulations: Dissolution in biorelevant media and antiproliferative activity on MCF-7 cell line

TİMUR B., VARAN G., OLĞAÇ S., YILMAZ USTA D., TEKSİN Z. Ş.
JOINT EUFEPS - ÖPhG Meeting 2025, Viyana, Austria, 19 - 21 February 2025, (Summary Text)

5. Exploring Protease Enzyme Selection for Protein-Structured Active Ingredient Loaded Drug Formulation with Molecular Dynamics Simulations

OLĞAÇ S., OLĞAÇ A., TEKSİN Z. Ş.
21st International Pharmaceutical Technology Symposium, Ankara, Turkey, 9 - 11 September 2024, (Summary Text)

6. Development of Recombinant Human Interleukin-2 Loaded Double Nanoemulsions Using Microfluidizer® for Oral Drug Delivery

OLĞAÇ S., TEKSİN Z. Ş.
21st International Pharmaceutical Technology Symposium, Ankara, Turkey, 9 - 11 September 2024, (Summary Text)

7. Evaluation of EXE-loaded SNEDDS using simultaneous lipolysis/ex-vivo permeability and lipolysis/in situ single-pass intestinal perfusion method

Timur B., Olğaç S., Yılmaz Usta D., Demirel M. A., Teksin Z. Ş.
21st International Pharmaceutical Technology Symposium, Ankara, Turkey, 9 - 11 September 2024, (Summary Text) Sustainable Development

8. Screening and assessment of excipients for nanoemulsion formulationsof interleukin-2 with computational studies

Olğaç S., Olğaç A., Teksin Z. Ş.
EUFEPS Annual Meeting 2023, Lisbon, Portugal, 31 May - 02 June 2023, (Summary Text)

9. Histology and pharmacodynamic echocardiography studies of bosentan-loaded SNEDDS and S-SNEDDS: New oral drug delivery systems for pulmonary arterial hypertension

Yılmaz Usta D., Olğaç S., Demirel M. A., Kula S., Kavgacı A., Sezginer P., et al.
EUFEPS Annual Meeting 2023, Lizbon, Portugal, 31 May - 02 June 2023, pp.165, (Summary Text)

10. Assessment of in vitro digestion for exemestane-loaded lipid-based formulations

Timur B., Yılmaz Usta D., Teksin Z. Ş.
FIGON DMD & EUFEPS Annual Meeting 2022, Leiden, Netherlands, 1 - 03 June 2022, pp.45-46, (Summary Text) Sustainable Development

11. Evaluation of pharmacokinetic and pharmacodynamic real-time biodistribution of bosentan formulations

Yılmaz Usta D., Teksin Z. Ş.
FIGON DMD & EUFEPS Annual Meeting 2022, Leiden, Netherlands, 1 - 03 June 2022, pp.47, (Summary Text) Sustainable Development

12. Bioequivalence and interchangeability issues in Modified Release Dosage Forms

TEKSİN Z. Ş.
20th International Pharmaceutical Technology Symposium, 21 February 2022, (Summary Text)

13. IN VITRO CHARACTERIZATION OF EXEMESTANE-LOADED SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM CONTAINING MEDIUM CHAIN MONO AND DIGLYCERIDES

Timur B., Yılmaz Usta D., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.37, (Summary Text)

14. MODELING AND COMPARISON OF IN VITRO DISSOLUTION PROFILES OF BOSENTAN MONOHYDRATE: COMMERCIAL TABLET VS S-SNEDDS TABLET

Yılmaz Usta D., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.35, (Summary Text)

15. SOLID-STATE CHARACTERIZATION STUDIES OF BOSENTAN-LOADED SOLID SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (S-SNEDDS) COMPRISING OF NEUSILIN® US2

Yılmaz Usta D., Olgac S., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.36, (Summary Text)

16. DEVELOPMENT OF IN VITRO LIPOLYSIS-PERMEATION METHOD TO ESTIMATE ORAL ABSORPTION OF EXEMESTANE-LOADED LIPID-BASED FORMULATION

Timur B., Yılmaz Usta D., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.30, (Summary Text)

17. DEVELOPMENT AND VALIDATED OF UV SPECTROPHOTOMETRIC AND HPLC METHOD OF BOSENTAN MONOHYDRATE FOR IN VITRO AND EX-VIVO SAMPLES

Yılmaz Usta D., Olgac S., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, pp.33, (Summary Text)

18. Structure-Guided Selection of Suitable Nanoemulsion Formulation Components for a Recombinant Form of Human Interleukin-2 (Aldesleukin)

Olğaç S., Olğaç A., İnceçayır T., Teksin Z. Ş.
3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8 - 10 September 2021, (Summary Text)

19. Evaluation of Bosentan-Loaded Self-nanoemulsifying Drug Delivery Systems Containing Peceol

YILMAZ USTA D., TEKSİN Z. Ş.
Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 July 2021, (Summary Text)

20. Assessment The Correlation Between In Vitro Dissolution and In Vitro Intestinal Lipolysis Data for Bosentan Loaded Lipid-Based Formulations

TİMUR B., YILMAZ USTA D., TEKSİN Z. Ş.
Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 July 2021, (Summary Text)

21. Evaluation of Ex-vivo Permeability and In Vitro Dissolution of BOS-loaded S-SNEDDS Tablets

YILMAZ USTA D., TEKSİN Z. Ş.
Controlled Release Society (CRS) 2021 Virtual Annual Meeting, 25 - 29 July 2021, (Summary Text)

22. Modeling and comparison of in vitro dissolution profiles of naproxen sodium tablets in biorelevant media

OLĞAÇ S., YILMAZ USTA D., DEMİRDAŞ B., ERMAN N. A., TEKSİN Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

23. Validated HPLC Method for the Determination of Tenofovir and its Application for In-Vitro and Ex-Vivo Investigations of Tenofovir Loaded Double Nanoemulsion

Olğaç S., Yılmaz Usta D., Erman N. A., İnceçayır T., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

24. Evaluation and Comparison of Β-Cyclodextrin Derivatives on Aqueous Solubility of Desloratadine

Çakmakyapan Ö., Tuğcu Demiröz F. N., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

25. Evaluations of Fasted and Fed Bioavailabilities of Self Double Emulsifying Drug Delivery System of Tenofovir

Bektaş D., Tuğcu Demiröz F. N., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

26. Biopharmaceutics Classification System (BCS) Based Biowaiver Approach in Turkey

Köksal H. T., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

27. Development and Optimization of an Antihypertensive Fixed-Dose Combination Using Plackett-Burman Design

Sarısaltık Yaşın D., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

28. DEVELOPMENT AND OPTIMIZATION OF SELFNANOEMULSIFYING DRUG DELIVERY SYSTEM OF BOSENTAN USING BOX BEHNKEN DESIGN

Yılmaz Usta D., Teksin Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

29. Evaluation of in vitro-in vivo relationship: Bosentan-loaded lipid based formulation versus commercial product

TİMUR B., YILMAZ USTA D., TEKSİN Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

30. Comparison of biorelevant dissolution of medium chain mono and diglycerides based bosentan-loaded self-nanoemulsifying formulations

YILMAZ USTA D., TEKSİN Z. Ş.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 22 - 25 June 2021, (Summary Text)

31. In vitro, ex-vivo, and in vivo evaluation of Bosentan-loaded self nanoemulsifying drug delivery system

Yılmaz Usta D., Timur B., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, Sweden, 7 - 09 June 2021, pp.90-91, (Summary Text)

32. Evaluation of In-vitro Dissolution Ex-vivo Permeability of Tenofovir Double Nanoemulsion Produced with the High Energy Method for Oral Drug Administration

Olğaç S., Yılmaz Usta D., İnceçayır T., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, Sweden, 7 - 09 June 2021, pp.65-66, (Summary Text)

33. The Development of Exemestane-loaded Self-nanoemulsifying Drug Delivery System

Timur B., Yılmaz Usta D., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, Sweden, 7 - 09 June 2021, pp.65, (Summary Text)

34. Enhancement of in vitro dissolution, in vitro lipolysis, ex-vivo permeability, and fasted and fed state bioavailability of Bosentan-solid SNEDDS: New oral drug delivery system for pulmonary arterial hypertension

Yılmaz Usta D., Olğaç S., Timur B., Teksin Z. Ş.
EUFEPS Annual Meeting 2021, Stockholm, Sweden, 7 - 09 June 2021, pp.91-92, (Summary Text)

35. Development and In Vitro Characterization of Bosentan-Loaded Self-Nanoemulsifying Drug Delivery System

Yılmaz Usta D., Teksin Z. Ş.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Vienna, Austria, 11 May 2021, (Full Text)

36. Investigation of Nanostructured Lipid Carriers (NLC)-Based Gel for the Transdermal Delivery of Ibuprofen: Preparation, Characterization, Textural Properties, and Ex Vivo Skin Permeation Studies

Yılmaz Usta D., Tuğcu Demiröz F. N., Teksin Z. Ş.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Vienna, Austria, 11 May 2021, (Full Text)

37. Production of Different Nanoemulsions with High Energy Method for Oral Drug Delivery

Olğaç S., İnceçayır T., Teksin Z. Ş.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Vienna, Austria, 11 - 14 May 2021, (Full Text)

38. Comparison of In Vitro Lipolysis of Bosentan-Loaded Lipid-Based Formulations in Fasted State Biorelevant Media

Timur B., Yılmaz Usta D., Teksin Z. Ş.
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Vienna, Austria, 11 May 2021, (Full Text)

39. Formulation Development Of Orodispersible Film and Evaluation of Disintegration Methods

Çakmakyapan Ö., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.
8th BBBB Conference on Pharmaceutical Sciences, Turkey, 14 - 16 October 2019, (Full Text)

40. Evaluation of Fasted and Fed State Intestinal In Vitro Lipolysis Test for Bosentan Loaded Lipid-Based Drug Delivery Systems

TİMUR B., OLĞAÇ S., YILMAZ USTA D., TEKSİN Z. Ş.
8th BBBB International Conference on Pharmaceutical Science, İzmir, Turkey, 14 - 16 October 2019, (Full Text)

41. Development and Characterization of Bosentan Loaded Solid Self Nanoemulsifying Drug Delivery System (S-SNEDDS)

YILMAZ USTA D., OLĞAÇ S., TEKSİN Z. Ş.
8th BBBB Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, (Full Text)

42. Formulation development of a fixed dose combination of amlodipine besylate and enalapril maleate using quality by design approach

SARISALTIK YAŞIN D., TEKSİN Z. Ş.
8th BBBB International Conference on Pharmaceutical Science, 14 - 16 October 2019, (Full Text)

43. Role of Surfactants and pH on Dissolution Behavior of Tamoxifen, a Weakly Basic BCS Class II Drug

OLGAÇ S., YILMAZ USTA D., İNCEÇAYIR T., TEKSİN Z. Ş.
AAPS PharmSci 360 Annual Meeting, Walter E. Washington Convention Center, Washington DC, USA, November 4-7, 2018, Washington, Kiribati, 4 - 08 November 2018, (Summary Text)

44. Modeling and Comparison of In-Vitro Dissolution Profiles of Tamoxifen Citrate Immediate Release Tablets

YILMAZ USTA D., OLGAÇ S., İNCEÇAYIR T., TEKSİN Z. Ş.
19th International Pharmaceutical Technology Symposium (IPTS 2018), Antalya, Turkey, p: 168-169, September 17-19, 2018, Antalya, Turkey, 17 - 19 September 2018, pp.168-169, (Full Text)

45. Development and validation of an HPLC method for amlodipine besylate and enalapril maleate using an experimental design and its application to solubility and dissolution tests

SARISALTIK YAŞIN D., ARSLANTÜRK BİNGÖL A., KARAKÜÇÜK A. E., TEKSİN Z. Ş.
12th of International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 June 2018, (Full Text)

46. Preparation And Characterization Of W/ O/ W Double Emulsion Containing Tenofovir

BEKTAŞ D., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.
12th International Symposium On Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 26 - 29 June 2018, (Summary Text)

47. MECHANICAL PROPERTIES AND EX-VIVO SKIN PERMEATION EVALUATIONS OF IBUPROFEN EMULSION GEL FOR TOPICAL DELIVERY

YILMAZ USTA D., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.
ISOPS 2018, Ankara, Turkey, 26 - 29 June 2018, (Summary Text)

48. Enhancement of Oral Bioavailability of Poorly Soluble Drug Tamoxifen Through Complexation with Different Cyclodextrins

ERDOĞAR N., TEKSİN Z. Ş., NEMUTLU E., İSKİT A. B., BİLENSOY E.
International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 June 2018, (Full Text)

49. Preparation And Analysis Of In Vitro- In Vivo Correlation Of Ritonavir Nanosuspensions

KARAKÜÇÜK A. E., EROĞLU H., TEKSİN Z. Ş., ÇELEBİ F. N.
EUFEPS Annual Meeting, Greece, 24 - 26 May 2018

50. The Gastrointestinal Lipolysis Model For Self-nanoemulsifying Drug Delivery System Of Tenofovir

BEKTAŞ D., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.
EUFEPS Annual Meeting, Greece, 24 - 26 May 2018

51. THE DEVELOPMENT OF SNEDDS CONTAINING BOSENTAN USING LONG CHAIN MONO AND DIGLYCERIDE MIXTURES

YILMAZ USTA D., TEKSİN Z. Ş.
European Federation for Pharmaceutical Sciences (EUFEPS) Annual Meeting 2018, Atina, Greece, 24 - 26 May 2018, (Summary Text)

52. Enhancement of Oral Bioavailability of Poorly Water Soluble Drug Tamoxifen Through Complexation with Different Cyclodextrins

ERDOĞAR N., NEMUTLU E., İSKİT A. B., TEKSİN Z. Ş., BİLENSOY E.
EUFEPS Annual Meeting 2018, 24 - 26 May 2018, (Summary Text)

53. Development And In Vitro Evaluation Of Lipid-base Self-nanoemulsifying Drug Delivery Systems Of Tenofovir

BEKTAŞ D., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.
11th World Meeting On Pharmaceutics, Biopharmaceutics And Pharmaceutical Technology, Spain, 19 - 23 March 2018

54. Construction of Pseudo-Ternary Phase Diagrams for the Preformulation SNEDDS Development of Bosentan, a BCS Class IIa

Yılmaz Usta D., Teksin Z. Ş.
11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Spain, 19 - 22 March 2018, (Full Text)

55. Evaluation of Water and Oil Solubilities of Bosentan, a BCS Class IIa Drug

YILMAZ USTA D., TEKSİN Z. Ş.
2nd International Gazi Symposium Series, Ankara, Turkey, 11 - 13 October 2017, (Summary Text)

56. DEVELOPMENT OF VALIDATED UV SPECTROPHOTOMETRICASSAY OF TENOFOVIR

Bektaş D., TUĞCU DEMİRÖZ F. N., TEKSİN Z. Ş.
2nd International Gazi Symposium Series, Ankara, Turkey, 11 - 13 October 2017, (Summary Text)

57. EVALUATION OF CYTOTOXIC EFFECT OF BIORELEVANT MEDIA ON CACO-2 CELL LINE

SARISALTIK YAŞIN D., TEKSİN Z. Ş., YILMAZ Ş.
2nd International Gazi Pharma Sypmposium Series, 10 - 13 October 2017, (Summary Text)

58. Evaluation of fasted and fed bioavailabilities of ritonavir nanosuspension in rats

KARAKÜÇÜK A. E., TEKSİN Z. Ş., ÇELEBİ F. N.
Controlled Release Society Annual Meeting Exposition, 16 - 19 July 2017, (Summary Text)

59. In vitro CACO-2 cell permeability studies of ritonavir nanosuspension formulation

KARAKÜÇÜK A. E., ÖZTÜRK N., VURAL İ., TEKSİN Z. Ş., ÇELEBİ F. N.
6th FIP Pharmaceutical Sciences World Congress 2017, 21 - 24 May 2017, (Summary Text)

60. Evaluation of solubility and dissolution of ritonavir nanosuspensions

KARAKÜÇÜK A. E., ÇELEBİ F. N., TEKSİN Z. Ş.
4th Congress on Innovation in Drug Delivery Site-Spesific Drug Delivery, Antibes, France, 25 - 28 September 2016, (Summary Text)

61. EVALUATION OF IN VITRO DISSOLUTION CHARACTERISTICS OF NON STEROIDAL ANTIINFLAMMATORY DRUGS IN THE TURKISH DRUG MARKET 2 IBUPROFEN A BCS CLASS IIa DRUG

SARISALTIK YAŞIN D., BEKTAŞ D., USLU A., ÖKÇELİK C., TEMEL H., TEKSİN Z. Ş.
International Gazi Pharma Symposium Series, Antalya, Turkey, 12 - 15 November 2015, pp.104

62. EVALUATION OF IN VITRO DISSOLUTION CHARACTERISTICS OF NON STEROIDAL ANTIINFLAMMATORY DRUGS IN THE TURKISH DRUG MARKET 1 FLURBIPROFEN A BCS CLASS IIa DRUG

YILMAZ USTA D., demirtaş ö., uslu a., cumhur ö., TEKSİN Z. Ş.
International Gazi Pharma Symposium Series, Antalya, Turkey, 12 - 15 November 2015, pp.103, (Summary Text)

63. Üniversitelerin Ar Ge ve İnovasyondaki Rolü

TEKSİN Z. Ş.
Osmangazi Üniversitesi Fen Edebiyat Fakültesi Kimya Bölümü Semineri, Eskişehir, Turkey, 17 April 2015

64. Effect of stabilizers on the particle size reduction and physical stability of ritonavir nanosuspensions

KARAKÜÇÜK A. E., ÇELEBİ F. N., TEKSİN Z. Ş.
2014 AAPS Annual Meeting and Exposition, 2 - 06 November 2014, (Summary Text)

65. Kişiye Özgü Tedavinin Farmakokinetik ve Farmakodinamik Yönü

TEKSİN Z. Ş.
12. Türkiye Eczacılık Kongresi, Ankara, Turkey, 25 - 27 September 2014

66. Biorelevant Dissolution Studies of Ezetimibe a BCS Class II Drug

BAYKA Ç., ORAN U., ADIYAMAN M., TEKSİN Z. Ş.
International Multidisciplinary Symposium on Drug Research & Development, Antalya, Turkey, 28 - 30 November 2013

67. Implementation of BCS based biowaiver in Turkey BCS Class II drugs

TORT S., KÖKSAL H. T., TEKSİN Z. Ş.
International Multidisciplinary Symposium on Drug Research & Development, Antalya, Turkey, 28 - 30 November 2013

68. BA BE studies for anticancer drugs

TEKSİN Z. Ş.
International Multidisciplinary Symposium on Drug Research & Development, Antalya, Turkey, 28 - 30 November 2013

69. Ekonomik Büyüme ve Sosyal Gelişme için Ar-Ge ve İnovasyon

TEKSİN Z. Ş.
Ar-Ge Merkezleri Zirvesi 2013, Gündem: İnovasyon ve Ekosisteminde Ar-Ge Merkezlerinin Rolü, Turkey, 15 - 16 November 2013 Sustainable Development

70. Biowaiver approach for BCS Discussion of biowaiver monographs for immediate release solid oral dosage forms

TEKSİN Z. Ş.
5th BBBB International Conference, Atina, Greece, 26 - 28 September 2013

71. Implementation of BCS Based Biowaiver in Turkey

TORT S., Tunç H. K., TEKSİN Z. Ş.
5th BBBB International Conference, 2013, Turkey, 26 September 2013, (Summary Text)

72. Importance of Biorelevant Dissolution in Drug Development For Poorly Soluble Drugs and Food Effect Studies

TEKSİN Z. Ş.
18th International Symposium on Microencapsulation, Antalya, Turkey, 12 - 14 September 2011

73. The use of biorelevant dissolution media to forecast the in vivo performance of BCS Class 2 drug Flurbiprofen

TEKSİN Z. Ş.
The 3rd PharmSciFair, Prag, Czech Republic, 13 - 17 June 2011

74. Comparison of Drug Permeabilities and BCS Classification Three Lipid Component PAMPA System Method versus Caco 2 Monolayers

TEKSİN Z. Ş., SEO P., POLLI J.
FIP Pharmaceutical Sciences 2010 World Congress with AAPS Annual Meeting, New Orleans, United States Of America, 14 - 18 November 2010

75. Improved Oral Absorption of Salmon Calcitonin with AT1002 Peptide

TAMIZ A., TEKSİN Z. Ş., SONG K., TRIPATHI A., EDDINGTON N.
ACS Meeting Medicinal Chemistry, 237th Spring National Meeting, SALT LAKE CITY, United States Of America, 22 - 26 March 2009

76. Evaluation of the P glycoprotein Abcb 1 Affinity Status of Salvinorin A

TEKSİN Z. Ş., HASSAN H., PRISINZANO T., EDDINGTON N.
AAPS Annual Meeting, Atlanta, United States Of America, 16 - 20 November 2008

77. Enhancement of Bioavailability of Abacavir using AT1002 The Tight Junction Modulator Synthetic Peptide AT1002

TEKSİN Z. Ş., FASANO A., EDDINGTON N.
Innovation in Drug Delivery from Biomaterials to Devices, Naples, Italy, 30 September - 03 October 2007

78. Performance of A PAMPA A Three Lipid PAMPA System and Comparing PAMPA and Caco 2 Permeability

TEKSİN Z. Ş., POLLI J.
Controlled Release Society-CRS 2007, Kaliforniya, United States Of America, 7 - 11 July 2007

79. AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Biovailability of Cyclosporin A via Intranasal Dosing

TEKSİN Z. Ş., SONG K., FASANO A., EDDINGTON N.
AAPS Annual Meeting, Texas, United States Of America, 29 October - 02 November 2006

80. Investigation of Ion Pair Mediated Transport of Metoprolol across Parallel Artificial Membrane Permeability Assay PAMPA Membranes

TEKSİN Z. Ş., HOM K., BALAKRISHNAN A., POLLI J.
AAPS Annual Meeting, Texas, United States Of America, 29 October - 02 November 2006

81. Evaluation of The Transport In Vitro Metabolism and Pharmacokinetics of Salvinorin A a Potent Hallucinogen

TEKSİN Z. Ş., LEE I., NEMIEBOKA N., OTHMAN A., UPRETI V., SYED S., et al.
AAPS Annual Meeting, Texas, United States Of America, 29 October - 02 November 2006

82. AT1002 Tight Junction Modulator Synthetic Peptide as Enhancers for Systemic Bioavailability of Therapeutic Agent via Intranasal Dosing

TEKSİN Z. Ş., EDDINGTON N., SONG K.
University of Maryland School of Pharmacy Annual Research Day, BALTIMORE, United States Of America, 17 May 2006

83. The Use of Biopharmaceutic Classification System in Drug Discovery and Development

TEKSİN Z. Ş.
Biopharmaceutical Classification System (BCS) and Enhancement of Bioavailability Through Smart Formulation-Workshop, İstanbul, Turkey, 29 - 30 September 2005

84. Delta G and AT1002 as Enhancers for Therapeutic Agent Delivery via Oral BBB and Intranasal Dosing

EDDINGTON N., TEKSİN Z. Ş., SONG K., FASANO A.
Annual National Institute of Biomedical Imaging and Bioengineering (NIBIB) Grantee Meeting, Washington, Kiribati, 8 - 09 August 2005

85. Ion Paired Mediated Transport of Metaporolol across Parallel Artificial Membrane Permeability Assay PAMPA Membranes

TEKSİN Z. Ş., SEO P., KAO J., POLLI J.
University of Maryland School of Pharmacy Annual Research Day, BALTIMORE, United States Of America, 11 May 2005

86. The BBB Transport Metabolism and Pharmacokinetics of Salvinorin A

TEKSİN Z. Ş., UPRETI V., OTHMAN A., SYED S., MENON D., LEE I., et al.
University of Maryland School of Pharmacy Annual Research Day, BALTIMORE, United States Of America, 11 May 2005

87. Mechanisms of Metoprolol Transport across Parallel Artificial Membrane Permeability Assay PAMPA Membranes

TEKSİN Z. Ş., LEE I., KAO J., POLLI J.
AAPS Annual Meeting, Baltimore, United States Of America, 7 - 11 November 2004

88. Influence of Lipid Composition on Drug Permeability and Performance of a Three Lipid PAMPA System

TEKSİN Z. Ş., SEO P., POLLI J.
University of Maryland School of Pharmacy Annual Research Day, BALTIMORE, United States Of America, 27 April 2004

89. Comparison Of Hematological Effects Of Commercial Product (Trental) And Developed A New Pentoxifylline Tablet Formulation Containing Semi- Natural Polymer Of Chitosan

YAMAÇ K., TEKSİN Z. Ş., AĞABEYOĞLU T. İ., KAPTAN M. K., BEYAN C.
The First National Congress On Thrombosis With International Participation, İstanbul, Turkey, 30 September - 02 October 2000

90. In Vitro Release Studies of Commercial and Developed Pentoxifylline Tablet Formulation Containing Various Amounts of Chitosan and Comparison of Its Bioavailability with a Commercial Product

TEKSİN Z. Ş., AĞABEYOĞLU T. İ.
10th Inter.Pharm. Technol.Symp. (IPTS-2000), İstanbul, Turkey, 11 - 13 September 2000

91. The Validation of High Performance Liquid Chromatographic HPLC Method of Pentoxifylline for Pharmacokinetic Bioequivalence Studies

AĞABEYOĞLU T. İ., TEKSİN Z. Ş.
The Second Int.Post.Res.Symp.Pharm., IPORSIP-2000, İstanbul, Turkey, 6 - 08 September 2000

92. Pharmacokinetic Modeling of Pentoxifylline Tablet Formulations

AĞABEYOĞLU T. İ., TEKSİN Z. Ş.
World Congress on Medical Physics and Biomedical Engineering, CHICAGO, United States Of America, 23 - 28 July 2000

93. Comparison of Bioavailability of a Chitosan Tablet Formulation of Pentoxifylline with a Commercial Product Trental

TEKSİN Z. Ş., AĞABEYOĞLU T. İ., YAMAÇ K.
Proceed. of the 27th Int’l.Symp.Control.Rel.Bioact.Mater., Paris, France, 7 - 13 July 2000

94. Determination of Steady State Plasma Concentrations of Tenoxicam in Osteoarthritic Patients Using HPLC

AĞABEYOĞLU T. İ., TEKSİN Z. Ş., ÇUBUKÇU FIRAT S., SEPİCİ V.
The First International Postgraduate Research Symposium on Pharmaceutics (IPORSIP), İstanbul, Turkey, 24 - 25 July 1998

95. Kinetics of Protein Binding of Tenoxicam

TEKSİN Z. Ş., AĞABEYOĞLU T. İ.
7th Int.Pharm. Techn.Symp. (IPTS), Ankara, Turkey, 12 - 14 September 1994
Books 9

1. Farmasötik Teknoloji Laboratuvar Kitabı

Acartürk F., İlbasmış Tamer S., İnceçayır T., Mutlu Ağardan N. B., Takka S., Teksin Z. Ş., et al.
Gazi Üniversitesi Yayınları, Ankara, 2023 Sustainable Development

2. Dozaj Şekilleri

ÇAPAN Y., SAVAŞER A., KANTARCI A. G., KARATAŞ A., ARICA YEGİN B., HASÇİÇEK C., et al.
in: Türk Farmakopesi 2017-II, Dr. ALİ ALKAN, ERAY KAPLAN, OĞUZHAN KOYUNCU, SELİN ERGÜN AYAN, Editor, SAĞLIK BAKANLIĞI, Ankara, pp.969-1014, 2018

3. Farmasötik Teknoloji

Acartürk F., Gürsoy R. N., Çapan Y., Savaşer A., Kantarcı A. G., Özgüney I., et al.
in: TÜRK FARMAKOPESİ, -, Editor, Artı 6 Yayınevi, Ankara, pp.1, 2017

4. Türk Farmakopesi II Monograflar Avrupa Farmakopesi Adaptasyonu 2016

ÖZKAN Y., SALTAN H. G., SARAÇ TARHAN S., ÖZKAN S. A., AYDIN A., SÜZEN H. S., et al.
TC SAĞLIK BAKANLIĞI TTİCK, 2016

5. Biyoyararlanım Biyoeşdeğerlik, Referans İlaç, Eşdeğer İlaç, Biyomuafiyet Kavramları ve Eşdeğer İlaçlarda Yasal Uygulamalar

TEKSİN Z. Ş.
in: Eczacının Başvuru Rehberi, Cengiz Yakıncı, Göknur Aktay, Editor, Türk Eczacılar Birliği, Fersa Ofset, Ankara, Ankara, pp.405-410, 2015

6. Farmasötik Teknoloji Laboratuvar Kitabı 4 Baskı

ACARTÜRK F., AĞABEYOĞLU T. İ., ÇELEBİ F. N., DEĞİM İ. T., DEĞİM Z., İLBASMIŞ TAMER S., et al.
ŞAFAK MATBACILIK SANAYİİ, Ankara, 2007

7. Farmasötik Teknoloji Laboratuvar Kitabı

ACARTÜRK F., AĞABEYOĞLU T. İ., ÇELEBİ F. N., DEĞİM İ. T., DEĞİM Z., DOĞANAY T., et al.
ŞAFAK MATBAACILIK SAN. TiC. L TO. ŞTi., Ankara, 2007

8. Farmasötik Teknoloji Laboratuvar Kitabı

ACARTÜRK F., AĞABEYOĞLU T. İ., ÇELEBİ N., DEĞİM İ. T., DEĞİM Z., DOĞANAY T., et al.
-, 2007

9. Farmasötik Teknoloji Laboratuvar El Kitabı

AĞABEYOĞLU T. İ., DOĞANAY T., ÇELEBİ N., ACARTÜRK F., TIRNAKSIZ F. F., OCAK Ö., et al.
-, 1999
Metrics

Publication

186

Publication (WoS)

26

Publication (Scopus)

23

Citation (WoS)

427

H-Index (WoS)

11

Citation (Scopus)

494

H-Index (Scopus)

11

Citation (Scholar)

715

H-Index (Scholar)

14

Citation (TrDizin)

1

H-Index (TrDizin)

1

Citation (Sum Other)

7

Project

19

Intellectual Property

8

Thesis Advisory

9

Open Access

12
UN Sustainable Development Goals